Journalist

&
""
Latest by
  • Tim Curry, Star of Home Alone 2 and It, Dies at 80
    Tim Curry, Star of 'Home Alone 2' and 'It,' Dies at 80 Tim Curry, the British actor known for his memorable roles as the hotel manager in 'Home Alone 2' and Pennywise in Stephen King's 'It,' has died at the age of 80.Curry passed away on August 25 at his home in Los Angeles, according to his long-time manager and friend, Marsha Hurwitz. The cause of death has not been disclosed. The Los Angeles police also responded to the home and conducted an investigation but found no suspicious circumstances.Born in 1946 in Cheshire, England, Curry studied theater at the University of Birmingham and had a career spanning nearly 60 years on stage and screen. He gained international fame for his role as the eccentric scientist Dr. Frank N. Furter in the 1975 cult classic 'The Rocky Horror Picture Show,' where he created an iconic character with his unique charisma and commanding stage presence.Following this, Curry portrayed a variety of memorable villains and characters in films such as 'Annie,' 'Clue,' and 'Legend.' He is particularly familiar to audiences for his role as the grumpy hotel manager in 'Home Alone 2: Lost in New York.'Online communities and social media have frequently referenced Curry's portrayal of Pennywise in the 1990 TV miniseries 'It,' based on Stephen King's novel. His performance left a lasting impression, combining humor and horror.In his later years, Curry faced health challenges. After suffering a stroke in 2012 or 2013, he began using a wheelchair, which limited his public appearances. However, he continued to participate in voice acting and fan events. 2026-08-27 09:04:00
  • LG Electronics and KEPCO Launch Smart Appliance Cashback Program
    LG Electronics and KEPCO Launch Smart Appliance Cashback Program LG Electronics is partnering with Korea Electric Power Corporation (KEPCO) to encourage the use of home appliances during off-peak hours. This initiative aims to transform appliances from mere electricity consumers into tools for managing power demand, thereby expanding the role of smart home services.On August 26, LG Electronics announced the signing of a memorandum of understanding (MOU) with KEPCO at the KEPCO Art Center in Yangjae, Seoul, to promote a 'Smart Appliance Cashback Program.'The program targets LG ThinQ-connected washing machines, dryers, dishwashers, and stylers, including combo washer-dryers. Customers who use these appliances during designated hours will receive a cashback of 100 won for every kWh of electricity consumed, with a maximum refund of 300 won per hour.The cashback applies during low electricity demand periods on weekends and holidays in spring and fall, specifically from 11 a.m. to 2 p.m. This initiative encourages appliance use during times of increased renewable energy generation, such as solar power, to alleviate pressure on the electricity supply.Utilizing appliance usage data to steer customers away from peak demand times could lay the groundwork for expanding home energy management services in the future.Customers can participate by signing up for KEPCO's Smart Appliance Cashback Service and linking it through the LG ThinQ app. The cashback will be automatically deducted from their electricity bill.LG Electronics plans to use this initiative to enhance energy efficiency in appliances and expand services that manage usage timing. The company has previously launched the 'ThinQ 26 Degree Challenge,' encouraging users to set their air conditioners to 26 degrees Celsius.Jung Ki-hyun, Vice President of LG Electronics' HS Platform Business Center, stated, 'We will promote a culture of smart energy use in collaboration with our customers based on LG ThinQ.'* This article has been translated by AI. 2026-08-27 09:04:00
  • Hana Securities Raises Target Price for BGF Retail, Citing Strong Performance Stability
    Hana Securities Raises Target Price for BGF Retail, Citing Strong Performance Stability Hana Securities has raised its target price for BGF Retail to 180,000 won, citing strong performance stability and potential for improved profitability. The investment recommendation remains a 'buy.'In a report released on the 27th, analyst Park Jong-dae explained that while the stagnation in store openings has led to a decline in convenience store growth rates, favorable operating conditions and improvements in product mix are positive factors.Park noted, "As the growth in the number of convenience store locations has reached its limit, BGF Retail is achieving both revenue growth and profitability improvements through enhanced micro-competitiveness. The company is also expanding services for foreign tourists and expatriates."He added that BGF Retail plans to increase the number of beauty-focused and grocery-specialized stores to 500 each by the end of the year to attract more female customers. Additionally, the company is expanding its offerings of health supplements and low-sugar products for senior customers, aiming to continuously improve gross profit margins.Park also mentioned that the expansion of overseas operations is another factor for potential profitability improvement. He noted that while same-store sales growth has slowed in the third quarter, the effects of consumer coupons from late July to early August last year have created a high base, and the heat wave in early August has reduced foot traffic.However, he stated, "As we approach the end of August, growth rates are recovering. The inbound effect from foreign tourists is stronger than in the second quarter, and the earlier Chuseok holiday in September is expected to boost third-quarter growth rates."* This article has been translated by AI. 2026-08-27 09:04:00
  • Celltrions Remsima SC and Jimpentra Achieve Combined Sales of 456.2 Billion Won in First Half
    Celltrion's Remsima SC and Jimpentra Achieve Combined Sales of 456.2 Billion Won in First Half Celltrion's subcutaneous formulation of infliximab, Remsima SC, and its U.S. brand name, Jimpentra, recorded combined sales of 456.2 billion won in the first half of this year, bringing the company closer to its goal of achieving annual sales of 1 trillion won. By product, Remsima SC, which is sold in Europe and South Korea, generated 356.7 billion won, a 20.3% increase compared to the same period last year. The U.S.-exclusive product, Jimpentra, saw sales soar to 99.5 billion won, a 176.4% increase. Celltrion explained that the growth, previously centered in Europe, is now diversifying with the rapid growth in the U.S. According to data from the pharmaceutical market research firm IQVIA, Remsima SC achieved a market share of approximately 32% in the five major European countries (EU5: Germany, France, Italy, Spain, and the UK) as of the first quarter of this year, marking the highest quarterly share since its launch in Europe in 2020. Germany had the highest share at 49%, meaning one in two patients receiving infliximab treatment was prescribed Remsima SC. France (35%) and Italy (31%) also showed broadening prescription bases. The growth of Remsima SC can be attributed to Celltrion's dual formulation strategy, which offers both intravenous (IV) and subcutaneous (SC) options. This allows healthcare providers to choose between hospital-administered IV and patient self-administered SC based on the patient's condition and treatment environment. This strategy has led to a trend where patients initially treated with Remsima transition to Remsima SC during maintenance therapy. Additionally, the European infliximab market has expanded at an average annual growth rate of about 9% from 2019 to 2024, providing a favorable environment for growth. Infliximab has been used for over 20 years to treat autoimmune diseases such as inflammatory bowel disease (IBD). In the U.S., Jimpentra, which is approved as a new drug in the subcutaneous formulation, saw sales in the first half of the year increase by 176.4% compared to the same period last year. Unlike the existing IV formulation, which requires patients to visit a hospital for administration, Jimpentra allows patients to self-inject in their preferred location, enhancing treatment convenience. Celltrion plans to expand its marketing to healthcare providers and patients based on insurance reimbursement and distribution networks in the U.S. to continue growing prescriptions and sales. In addition to expanding prescriptions and supply in existing markets, Celltrion is also entering new markets. The company plans to launch Remsima SC in Japan, a key market in Asia, next year. It will also gradually expand sales in Latin America according to the approval schedules of individual countries. A company official stated, "With stable growth in Europe and rapid growth in the U.S., our growth trajectory has diversified. We will continue to expand prescriptions in existing markets and proceed smoothly with the launches in Japan and Latin America to develop the Remsima SC product line into our second product to achieve annual sales of 1 trillion won, following Remsima."* This article has been translated by AI. 2026-08-27 09:00:20
  • SK Securities: SK Biopharm Secures Growth Momentum with New Drug Candidate
    SK Securities: SK Biopharm Secures Growth Momentum with New Drug Candidate SK Securities evaluated on the 27th that SK Biopharm has secured medium- to long-term growth momentum through the introduction of the epilepsy drug candidate 'Opacalime.' The target price remains at 160,000 won, with an investment recommendation of 'buy.' SK Biopharm announced on the 26th that it has signed an exclusive technology introduction agreement for the epilepsy drug candidate Opacalime and potassium channel drug discovery platform from Biohaven. The contract is valued at up to $795 million (approximately 1.996 trillion won), with a non-refundable upfront payment of $400 million (about 553.2 billion won). After commercialization, separate ongoing royalties will be paid based on net sales. Lee Sun-kyung, a researcher at SK Securities, stated, "The patent expiration for Exkopia is scheduled for 2032, making reliance on a single product a key factor in SK Biopharm's earnings volatility. Opacalime is noteworthy as it can target the same epilepsy market as Exkopia." The researcher added, "Opacalime not only has the potential to generate sales synergy with Exkopia but can also fill the revenue gap that may arise after the patent expiration. It is particularly significant that Opacalime demonstrates superior safety and tolerability compared to existing drugs." Opacalime is currently in Phase 2/3 clinical trials. The primary results of the first Phase 3 trial are expected to be released by the end of this year, while the second Phase 3 results are anticipated to be announced in early 2028. If positive data is obtained, the goal is to apply for FDA approval in the first half of 2028 and launch in the U.S. in the first half of 2029. The researcher noted, "Opacalime has shown competitive safety and tolerability data compared to Azetucalner in extended trials, and by securing a top-level candidate in the same mechanism, we can alleviate concerns about competitive product entry and reliance on a single product."* This article has been translated by AI. 2026-08-27 09:00:20
  • KAI Launches 24th Aerospace Paper Competition to Discover Talent
    KAI Launches 24th Aerospace Paper Competition to Discover Talent Korea Aerospace Industries (KAI) has begun accepting submissions for the 24th Aerospace Paper Competition, which is sponsored by the Aerospace Administration, the Korea Aerospace Industry Promotion Association, and the Korean Society for Aeronautics and Astronautics.This competition, which has been ongoing for over 20 years, aims to discover and nurture talent that will lead the future of South Korea's aerospace industry. It is open to all undergraduate and graduate students in South Korea who have an interest in the aerospace field.This year, the prize money has been significantly increased to promote academic research among aerospace talent. The top awards, the Aerospace Administration Award and the KAI CEO Award, will each provide 10 million won, an increase of 5 million won from last year, to two recipients. The excellence awards will each offer 5 million won, up by 1 million won, to two winners.Winners will also receive a special benefit of exemption from the document screening process during KAI's recruitment of new employees.The main technical areas for submissions include: mechanical, materials & processes, electronics & electrical, software, and policy & management. The application fields include manned and unmanned integrated systems (MUM-T), future software, next-generation platforms (fixed-wing, rotary-wing, unmanned aerial vehicles, and commercial aircraft), space solutions, and future aircraft (AAV), which are all key projects for KAI's future.The evaluation of the papers will be conducted jointly by KAI and the Korean Society for Aeronautics and Astronautics to ensure professionalism and fairness. Winners will be announced in early November, with an award ceremony scheduled for late November.The KAI Aerospace Paper Award is the only aerospace competition in South Korea that has been organized by a private company for over 20 years, successfully producing outstanding talent who have entered the relevant industries and academia, thereby contributing to the enhancement of the nation's aerospace competitiveness.KAI CEO Kim Jong-chul stated, "The aerospace industry is not only a core industry with infinite growth potential but also a key national competitiveness. It is essential to nurture and support related talent. KAI will take the lead in creating an ecosystem that encourages more talent to enter the aerospace field."* This article has been translated by AI. 2026-08-27 09:00:10
  • Huawei Bids for Egypt Data Center Project with Xi Jinpings Support
    Huawei Bids for Egypt Data Center Project with Xi Jinping's Support Chinese IT company Huawei has entered the bidding process for a data center construction project in Egypt. Observers expect that President Xi Jinping will lend his support to help Huawei secure the contract.According to Bloomberg, Huawei has proposed the establishment of an AI data center for public sectors, including military and security, to the Egyptian government. The proposal includes supplying 1,408 top-tier Ascend 950 series chips for AI training in the cloud. Additionally, 600 chips from the 950 series or the earlier 910B model will be used in two inference clusters. The data center will handle both training and inference tasks, all executed using Huawei's AI semiconductors. If successful, this bid would mark the first export of Huawei's Ascend accelerators after more than a year of attempts. Huawei has also outlined a 12-month roadmap for building the necessary infrastructure.Huawei's proposal for Egypt includes collaboration with iFlytek, a Chinese surveillance technology firm that has been on the U.S. sanctions list since 2019. iFlytek is recognized for its global competitiveness in AI image recognition.In response to this development, the U.S. is reportedly discussing the formation of a 'U.S. consortium' through the State Department to engage with American IT companies like Nvidia, AMD, and Microsoft to prevent Huawei from winning the contract. This situation has set the stage for a competitive landscape between the U.S. and China over the Egyptian data center project. Bloomberg cited a source familiar with Huawei's internal affairs, stating, "Recently, Huawei's strategies in Africa and the global market align with the Chinese government's diplomatic efforts," adding that Huawei is actively seeking government clients in African countries, including Egypt and Kenya, focusing on sectors like education and healthcare.President Xi Jinping is also expected to actively support Huawei's entry into Egypt. He is scheduled to visit Egypt soon for a summit with President Abdel Fattah el-Sisi. Given the competitive nature of the data center construction project with the U.S., it is likely that Xi will advocate for cooperation during his visit. This will be Xi's first visit to Egypt in a decade. He is set to travel to Bishkek, Kyrgyzstan, from August 30 to September 3 for the Shanghai Cooperation Organization summit before making a state visit to Cairo.* This article has been translated by AI. 2026-08-27 09:00:10
  • Krafton Unveils Publishing Strategy at Gamescom, Aims to Develop New Franchises Beyond PUBG
    Krafton Unveils Publishing Strategy at Gamescom, Aims to Develop New Franchises Beyond PUBG Krafton hosted a 'Krafton Media Day' at Gamescom 2026 in Cologne, Germany, where it announced its vision for developing global franchises. The company aims to continuously discover and nurture new global franchises that will follow in the footsteps of PUBG through a variety of genres, collaborations with creative studios, and reinterpretations of existing intellectual properties (IPs).The media day took place on August 26 at the Koelnmesse. Krafton introduced five new titles: No Low, Project Zeta, Age Twister, Tangle: Unbound, and PUBG: Deadnet, detailing their development backgrounds and core gameplay.Krafton also outlined its publishing direction, which includes challenging existing genre conventions, collaborating with innovative creative studios, and reinterpreting established franchises to connect with global fans in new ways.Jang Tae-seok, head of global publishing at Krafton and PUBG franchise lead, shared the company's publishing vision. He emphasized the goal of meeting more fans eager for new experiences by continuing to challenge itself alongside creative studios with diverse genres and identities.The first session featured Klass Af Biyurin, CEO of Neon Giant, who introduced the immersive open-world first-person shooter RPG, No Low. Neon Giant aims to create a highly engaging open-world experience where players can craft their own gameplay and narratives rather than following predetermined paths.Kim Nam-seok, CEO of Nirvana, presented Project Zeta, a multi-team tactical arena (MTA) game. Nirvana focuses on finding new thrills and excitement that MOBA fans desire, moving away from traditional genre formulas. The game features a structure where four teams of three players each compete for key objectives from the start.Jordi Ministral and Alexis Corominas, co-founders and directors of Piccolo Studio, introduced Age Twister, a two-player cooperative adventure. The game follows a grandfather and granddaughter as they navigate adventures across four life stages—childhood, youth, adulthood, and old age—integrating generational differences into gameplay and narrative.Gu In-young, CEO of Boundary, presented Tangle: Unbound, an Eastern dark fantasy action RPG. Tangle combines a world view centered on Buddhist concepts of reincarnation and karma with the aesthetics and imagination of East Asian culture from the 15th to 17th centuries. Boundary aims to create a new dark fantasy experience that incorporates Eastern mythology and cultural imagination into its world, combat, and narrative.Dave Curd, creative director at PUBG Studio, concluded the sessions by introducing the new title in the PUBG franchise, PUBG: Deadnet. This title reinterprets the survival and competition experiences gained from PUBG: Battlegrounds, moving beyond traditional battle royale formats. Set in a new world inspired by the Pacific Northwest of the United States in the 1990s, titled 'Cascadia 1996,' it aims to expand the PUBG identity in new ways and explore the franchise's potential.Krafton also showcased its new titles at Gamescom 2026, setting up a booth in Hall 9 of the Koelnmesse and providing a space for attendees to experience the games firsthand.Among the new titles, Age Twister, developed by Piccolo Studio, has been nominated for the 'Most Wholesome' category at the Gamescom Awards 2026, which honors games that provide warm and positive experiences to users. The winners will be announced on August 28. 2026-08-27 09:00:00
  • Hyundai Glovis Expands Air Freight for K-Beauty and K-Pop
    Hyundai Glovis Expands Air Freight for K-Beauty and K-Pop Hyundai Glovis' K-culture air forwarding business continues to grow. The company is expanding its transportation services to include high-value consumer goods such as popular Korean cosmetics and K-pop albums, as well as art pieces, while accelerating efforts to secure non-affiliated clients.On August 27, Hyundai Glovis announced that it has secured air transport contracts for cosmetics and albums with A.P.R. and SM Entertainment, and is currently transporting related shipments.A.P.R.'s cosmetics are being shipped to locations including Los Angeles, USA, London, UK, and Amsterdam, Netherlands, while SM Entertainment's albums are being sent to Chicago, USA. The air transport volume for the two companies contracted in the first half of the year amounts to several hundred tons.As a forwarder, Hyundai Glovis manages the entire transportation process, from cargo packaging to customs clearance, shipping, and arrival. The company negotiates with airlines to secure flights and transport routes, while also managing the shipping process according to the characteristics of each product.With the rapid increase in overseas demand for K-beauty and K-pop, the related air logistics market is also experiencing growth. According to customs statistics, the export value of domestic cosmetics to 58 European countries in the first half of this year reached 2.3113 trillion won, nearly doubling compared to two years ago.During the same period, the export value of K-pop albums surged 125% year-on-year to 382.3 billion won, marking the highest level ever recorded. Exports to the United States alone accounted for 110.1 billion won, the largest among export destinations.Hyundai Glovis is expanding its air forwarding services beyond general consumer goods to include high-value products in line with the growth of the global e-commerce market. Last month, the company entered the art transport market by shipping artwork by British contemporary artist Damien Hirst to London.Investment in infrastructure to expand air logistics operations is also ongoing. Earlier, Hyundai Glovis invested 200.6 billion won in a fund for the acquisition of Asiana Airlines' cargo division, formerly Air Incheon, to enhance its competitiveness in air logistics.Hyundai Glovis stated, "We plan to further strengthen our capabilities in related businesses based on our logistics center at Incheon International Airport, our own air logistics hub."Meanwhile, Hyundai Glovis is steadily increasing non-affiliated shipments in its core business of finished vehicle maritime transport. Last year, the share of non-affiliated revenue in the finished vehicle shipping (PCTC) sector reached 53%. The company is expanding its volume from European, North American, and Chinese automakers, reducing its reliance on affiliated shipments.* This article has been translated by AI. 2026-08-27 09:00:00
  • Kang Tae-young Joins Finance that Saves Lives Campaign
    Kang Tae-young Joins 'Finance that Saves Lives' Campaign Kang Tae-young, CEO of NH Nonghyup Bank, has joined a campaign aimed at preventing illegal financial activities and supporting vulnerable financial groups.On August 27, NH Nonghyup Bank announced that Kang participated in the 'Finance that Saves Lives Relay Campaign,' which aims to promote the value of inclusive finance by preventing financial harm to citizens and supporting economic recovery.The campaign is organized by the Korea Inclusive Finance Agency, with participation from officials of financial institutions and public organizations in a relay format. The campaign began with Kim Eun-kyung, head of the Korea Inclusive Finance Agency, followed by Cho Yong-byeong, chairman of the Korean Bankers Association, and Jeong Jin-wan, CEO of Woori Bank. Kang was nominated by Jeong as the next participant and chose Choi Woo-hyung, CEO of K-Bank, to follow him.Kang stated, "I feel a heavy responsibility knowing that many people are struggling due to illegal financial activities and excessive debt. I will continue to support vulnerable financial groups and lead efforts to realize the social value of finance."Meanwhile, NH Nonghyup Bank is expanding its inclusive finance programs to reduce the burden on vulnerable financial groups. In July, the bank introduced a special support system expected to alleviate approximately 200.6 billion won in debt for socially disadvantaged individuals. It is also operating a loan principal repayment program to ease the financial burden on farmers and individual business owners.* This article has been translated by AI. 2026-08-27 08:56:00